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Purpose: To compare the utility of a rating and visual analogue scale for the assessment of legibility in 
prescriptions 
Methods: A sample of fifty randomly selected prescriptions from a tertiary hospital in Benin City, Nigeria 
was assessed by five independent assessors – three doctors and two pharmacists using a rating scale 
and a 100 mm visual analogue scale. Rating scores were allocated as: 0 - completely illegible; 1 - 
barely legible; 2 - moderately legible; 3 - clearly legible, and 4 - print. Visual analogue scores were 
measured in millimetres. 
Results: Rating and visual analogue scores were skewed. The median rating score by doctors and 
pharmacists were 2.0 and 3.0, respectively. Median visual analogue scores were 59.5, 67.0, 55.0, 51.5 
and 46.0 mm, respectively. Inter-quartile ranges (rating scores) were 2.0 – 3.0 for both doctors and 
pharmacists except for one pharmacist whose inter-quartile range was 1.0 – 2.3; inter-quartile ranges 
(visual analogue scores) were 49.3 – 63.0, 59.8 – 71.0, 31.0 – 65.5, 40.8 – 62.0, 43.0 – 55.5 mm, for 
the five independent assessors. The pharmacists’ scores using either scale were significantly positively 
correlated (rs = 0.900; 2-tailed p = 0.05); one doctor’s scores were negatively correlated (rs = -0.308). 
Conclusion: The findings support the utility of both instruments in the assessment of handwriting but 
suggest that there may be important differences between doctors and pharmacists using either method. 
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INTRODUCTION 
 
Legibility of doctors’ handwriting has been 
assessed in many published reports, mostly 
from developed countries [1-4] where 
computer software that may be used for such 
assessments are available and more 
accessible than in developing countries.  
The poor handwriting of doctors is often joked 
about [5] and doctors have been shown to 
write less legibly than other health care 
professionals and administrative staff [3]. In a 
study of over one thousand prescriptions 
written by doctors in public and private 
hospitals in Nigeria, only 20% were clearly 
legible [6]. Until Computerized Order Entry 
systems (CPOEs) become widely available in 
developing countries, handwritten 
prescriptions will continue to be the main 
tools for exchange of information regarding 
therapeutic intent. Pharmacists (and other 
dispensers of medicines) will therefore 
continue to be challenged to decipher the 
contents of poorly legible prescriptions.  
 
In order to reproducibly assess handwriting 
legibility and monitor changes arising from 
interventions to improve doctors’ handwriting 
there have to be reliable means to assess 
legibility in the absence of computer software.  
This study compared the utility of two 
instruments - a rating scale and a visual 
analogue scale - for the assessment of 
legibility of handwriting in prescriptions 





A cross-sectional survey of hand-written 
prescriptions was conducted at the General 
Outpatients’ Department (GOPD) of the 
University of Benin Teaching Hospital, Benin 
City in southern Nigeria. Five doctors were 
selected by simple random sampling from a 
total of eight doctors consulting at the GOPD. 
Prescriptions written on the survey day were 
pooled and prescriptions written by the 
randomly selected doctors were sequentially 
selected with the intention of obtaining 10 
prescriptions per doctor until a total of 50 
prescriptions were obtained. Prescriber 
identities were obscured and 5 independent 
assessors (3 resident doctors in internal 
medicine and 2 pharmacists, each with over 
five years’ post-graduation working 
experience) assessed the legibility of 
handwriting in each prescription using a 5-
point rating scale and a 100-mm visual 
analogue scale in turn. Each assessor 
independently assessed all fifty prescriptions. 
These assessors worked in the Department 
of Medicine, the Main Pharmacy Laboratory 
and the Bulk Store of the hospital which are 
physically distant and operationally different 
from the GOPD. The GOPD had its own 
pharmacy with pharmacists attached to it.  
 
On the visual analogue scale 0 mm 
represented ‘most illegible handwriting ever’ 
and 100 mm ‘most legible handwriting ever’. 
The rating scale was an ordinal scale with 0: 
completely illegible; 1: barely legible; 2: 
moderately legible; 3: clearly legible and 4: 
print. Mean visual analogue scores were 
obtained by summing up the scores for each 
of the prescriptions assessed by individual 
prescribers and dividing by the number of 
prescriptions assessed. Mean rating scores 
were similarly derived. 
 
Data were analyzed using the Statistical 
Package for Social Sciences (SPSS) version 
13.0 software. Inferential statistics for skewed 
data were employed; correlation between 
rating and visual analogue scores was 
estimated using non-parametric statistics 
(Spearman correlation coefficient).  
 
Ethical approval was obtained from the 





Rating and visual analogue scores were 
provided for all fifty prescriptions by all the 
assessors,  except  that  one  pharmacist (by  
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Table 1: Handwriting scores using rating and  
visual analogue scales 
 
Assessment tool ( DS.±Χ ) 
Assessor* 
Rating scale** VAS** 
D1 2.3 ± 0.5 55.8 ± 12.0 
D2 2.4 ± 0.6 65.2 ± 10.8 
D3 2.2 ± 0.8 49.0 ± 19.3 
P1 2.5 ± 0.8 52.6 ± 14.8 
P2 1.9 ± 0.8 47.7 ± 9.2 
 
D1-3 = Doctors 1, 2 and 3; P1, 
 2 = Pharmacists 1 and 2; RAS = rating 
 scores (ordinal scale from 0-4); VAS = 
 visual analogue scores (in millimetres) 
 
 
error) did not provide a visual analogue score 
for one prescription. Handwriting scores by 
each independent assessor using either 
scale are presented in Table 1 as means with 
standard deviations Because the data were 
skewed they were subsequently analyzed 
using non-parameteric statistics. Median 
handwriting scores (with inter-quartile ranges) 
allocated by individual assessors are 
presented in Table 2. 
 
Handwriting scores were positively correlated 
except in one case (Table 3). Correlation was 
stronger for assessments undertaken by 
pharmacists (Spearman correlation coeffi-




In this study, legibility was assessed by 
experienced physicians and pharmacists and 
it is noteworthy that the lowest rating scores 
were assigned by a pharmacist. It is not 
possible, however, to hypothesize that 
pharmacists scored prescriptions more 
strictly than doctors because of the overlaps 
between scores assigned by the doctors and 
pharmacists.  
 
Evidence for the reliability of both the rating 
and visual analogue scales in the 
assessment of legibility is provided by the 
correlation coefficients observed. There was 
perfect correlation (Spearman coefficient of 
1.000) between the visual analogue scores of 
“Doctor 1” and “Pharmacist 2” and near-
perfect correlation between the visual 
analogue scores of “Doctor 3” and the rating 
scores of “Doctor 2”. Our data also provide 
evidence for the internal and external validity 
of the instruments used. 
 
The negative correlation coefficients obtained 
for one of the assessors appear to be ‘outlier’ 
data judging by the otherwise strong positive 
correlations between scores obtained using 
either instrument for other assessors. 
 
It appears that there was less variability with 
the scores obtained using the rating scale 
compared to the visual analogue scale, but 
this could be explained by the fact that the 
rating scale is a fixed interval scale unlike the  
    























Number 50 50 50 50 50 50 50 50 50 49 
Mean  2.3 2.4 2.2 2.5 1.9 55.8 65.2 49.0 52.6 47.7 
Median  2.0 2.0 2.0 3.0 2.0 59.5 67.0 55.0 51.5 46.0 
Percentile           
25 2.0 2.0 1.8 2.0 1.0 49.3 59.8 31.0 40.8 43.0 
50 2.0 2.0 2.0 3.0 2.0 59.5 67.0 55.0 51.5 46.0 
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VAS 0.8 0.8 0.7 0.7 0.9* 1.0 0.1 0.8 0.6 1.0** 
D2 
VAS -0.4 0.0 -0.3 -0.6 -0.2 0.1 1.0 -0.1 -0.7 0.1 
D3 
VAS 0.9 0.7 1.0** 0.8 0.9* 0.8 -0.1 1.0 0.6 0.8 
P1 
VAS 0.8 0.4 0.7 0.9* 0.7 0.6 -0.7 0.6 1.0 0.6 
P2  
VAS 0.8 0.8 0.7 0.7 0.9* 1.0** 0.1 0.8 0.6 1.0 
 
* Significant correlation at 0.05 level (2-tailed). 
** Significant correlation at 0.01 level (2-tailed). 
D1-3 = Doctors 1, 2 and 3; P1, 2 = Pharmacists 1 and 2; RAS = rating scores; VAS = visual 
analogue scores 
 
visual analogue scale which provides a 
continuum along which handwriting was 
scored. 
 
In a study which assessed patients’ 
experiences of pain relief with analgesic 
therapy, respondents preferred a visual 
analogue scale to a rating scale [7].  
 
It is difficult to suggest, on the basis our 
findings, which of the two instruments would 
be preferable for the assessment of legibility. 
Clearly, either the rating or visual analogue 
scale may be used.  
 
The differential performance between doctors 
and pharmacists with either instrument 
deserves further study before definite 
inferences can be drawn. It is debatable 
whether the performance of the pharmacists 
who assessed prescriptions is the result of 
individual skill in assessing legibility or 
whether it is a function of professional 
proficiency gained through several years of 
assessing doctors’ prescriptions.  
 
It would be worthwhile still to establish 
criterion validity for either of these 
instruments against a ‘gold standard’ for the 
assessment of legibility. Such a standard 
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